Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
The transcatheter embolization and occlusion devices market is experiencing rapid growth, driven by advancements in minimally invasive medical procedures and expanding applications across various medical fields. This sector is evolving swiftly, supported by technological innovations and increasing demand for precise, targeted therapies. Below is a detailed look at the market’s size, key growth drivers, segmentation, competitive landscape, and regional trends.
Steady Market Expansion in the Transcatheter Embolization and Occlusion Devices Market
The market for transcatheter embolization and occlusion devices has seen significant growth over recent years. It is projected to increase from $5.23 billion in 2025 to $5.79 billion in 2026, marking a compound annual growth rate (CAGR) of 10.6%. The earlier growth phase was largely fueled by the broader use of interventional radiology, the rising number of vascular disease cases, wider availability of catheter-based treatments, and a shift towards minimally invasive techniques supported by advances in imaging-guided interventions.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15944&type=smp
Anticipated Growth Trajectory Through 2030
Looking ahead, the market is expected to continue its strong upward trend, reaching $8.33 billion by 2030 with a CAGR of 9.5%. This forecasted expansion is attributed to growing demand for therapies that precisely target embolization, increased adoption of sophisticated embolic materials, and the broadening scope of oncology and neurointerventional procedures. The market is also benefiting from intensified investments in interventional healthcare infrastructure and a heightened emphasis on precision medicine. Key emerging trends include rising use of liquid embolic agents, detachable and coated coils, advanced image-guided techniques, and the development of precision occlusion technologies.
The Rising Popularity of Minimally Invasive Procedures Boosting Market Growth
One of the primary forces driving the transcatheter embolization and occlusion devices market is the increasing preference for minimally invasive surgery. These procedures involve small incisions or robotic tools that reduce tissue damage, leading to less trauma, faster recovery, diminished pain after surgery, and fewer complications. The growing patient awareness of these benefits, alongside technological advancements, is encouraging greater adoption of such methods.
Access The Complete Transcatheter Embolization And Occlusion Devices Market Report:
Devices Enabling Precision in Minimally Invasive Surgeries
Transcatheter embolization and occlusion devices play a vital role in supporting minimally invasive interventions by delivering treatments through catheters with high accuracy, causing minimal disturbance to surrounding tissues. For example, in January 2025, Intuitive Surgical, Inc. reported that global da Vinci robotic surgical procedures increased by about 17% in 2024 compared to 2023, with projections for a 13% to 16% rise in 2025. This trend highlights how the expanding use of robotic and catheter-based techniques is propelling the device market’s growth.
Detailed Segmentation Sheds Light on Market Opportunities
The transcatheter embolization and occlusion devices market is segmented by type, application, and end user. Types include coil devices and non-coil devices, with coil subcategories such as bare metal, surface coated, and detachable coils. Non-coil devices cover gelatin sponge, liquid embolic agents, and spheres and particles. Applications span peripheral vascular disease, oncology, neurology, urology, and other medical areas. End users comprise hospitals, ambulatory surgical centers, clinics, and other healthcare facilities. This detailed categorization helps identify specific revenue streams and growth potential within the sector.
Innovations in Liquid Embolic Systems Alter Market Dynamics
Leading companies in the market are focusing on developing advanced embolic solutions, especially liquid embolic systems designed for minimally invasive vascular therapies. These liquid systems consist of non-adhesive, polymer-based materials that are delivered via microcatheters and solidify upon contact with blood, allowing for precise occlusion of problematic vessels. For instance, in July 2025, Medtronic plc. introduced the Onyx Liquid Embolic System (LES) into clinical trials targeting arterial hemorrhage in peripheral vasculature. This product uses a polymer mixed with radiopaque powder, enabling real-time visualization and controlled delivery. The system enhances safety and precision, broadening treatment options while supporting minimally invasive workflows.
Major Industry Players Driving Market Progress
Key organizations shaping the transcatheter embolization and occlusion devices market include Johnson & Johnson Services Inc., Abbott Laboratories, Medtronic Inc., Stryker Corporation, Boston Scientific Corporation, Terumo Corporation, Teleflex Incorporated, Cook Medical, Merit Medical Systems Inc., Penumbra Inc., Sirtex Medical Limited, Cordis Corporation, pfm medical ag, Micro Interventional Devices Inc., Acandis GmbH, Metactive Medical Inc., Balt Group, Kaneka Medix Corporation, Shape Memory Medical Inc., and Boston Scientific Neurovascular. These companies focus on innovation and competitive product offerings to meet evolving clinical needs.
North America Holds the Largest Share in Market Revenue
In 2025, North America was the dominant region in terms of revenue for the transcatheter embolization and occlusion devices market. The analysis covers several regions including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa. While North America leads currently, other regions are also showing promising growth prospects as healthcare infrastructure and adoption of minimally invasive techniques expand globally.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
